Annie Killoran, M.D., M.Sc., B.Sc., B.A. (Resident in Chief)

Anticipated Residency Completion:

2010

Hometown:

Montreal, Canada.

Undergraduate Education:

• BSc: Life Sciences (First-class Honors), Queen’s University, Canada.
• BA: English literature (Honors),Trent University, Canada.- St. David’s University of Wales, UK. (1-year academic exchange)
• Teaching certification: English as a foreign language British Royal Society of Arts, Hungary.

Graduate Education and Medical School:

• M.D., University College Dublin, Ireland.
• MSc: Pathology: ‘Gene therapy for hemophilia: non-viral & viral in-vivo gene delivery mechanisms’, Queen’s University, Canada.

Post Graduate Education, Internship, and other training:

• Intern, Michigan State University/Sparrow Health Systems, 2006 - 2007.
• Resident, Michigan State University/Sparrow Health Systems Neurology Residency, 2007 - 2009.
• Chief Resident, Michigan State University/Sparrow Health Systems Neurology Residency, 2009 - 2010.

Fellowship interests/Special neurology interest:

Movement Disorders.

Research and publications:

• Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder?  Thompson MD, Killoran A, Percy ME, Nezarati M, Cole DEC, Hwang PA.  Journal of Pediatric Neurology. 2006 Apr; 34(4) 253-336.
• Characterization of SrgA, a Salmonella enterica serovar Typhimurium virulence plasmid-encoded paralogue of the disulfide oxidoreductase DsbA, essential for biogenesis of plasmid-encoded fimbriae. Bouwman CW, Kohli M, Killoran A, Touchie GA, Kadner RJ, Martin NL. Journal of Bacteriology. 2003 Feb;185(3):991- 1000.
• The canine factor VIII 3'-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivo. Notley C, Killoran A, Cameron C, Wynd K, Hough C, Lillicrap D. Human Gene Therapy 2002 Sep 1;13(13):1583-93.
• Hyperphosphatasia with mental retardation: a pyridoxine-responsive disorder? Thompson MD, Killoran A, Burnham WM, Percy ME, Nezarati M, Hwang PA, and Cole DEC.  J Clin Neurophysiol. S126. 2005 Oct; 22(5):370. ABSTRACT
• Hyperphosphatasia with cognitive deficit and seizures: further syndrome delineation. Nezarati M, Thompson MD, Dupuis L, Killoran A, Hwang PA, Cole DEC.  Eur J Hum Genet 13 Supp l1:104, 2005. ABSTRACT
• Hyperphosphatasia with cognitive deficit and seizures: further syndrome delineation. Nezarati M,   Thompson MD, Dupuis L, Killoran A, Hwang PA, Cole DEC. Eur Soc Hum Genet Annual Meeting. Prague, Czech Republic May 9, 2005. PRESENTATION
• Hyperphosphatasia with cognitive deficits.  Cole DEC, Killoran A, Nezarati M , Thompson MD,  Dupuis L, Hwang PA. Department of Pharmacology, Oxford University, United Kingdom. May 19, 2005. PRESENTATION
• Hyperphosphatasia with neurologic deficit.  Cole DEC, Killoran A, Nezarati M , Thompson MD,  Dupuis L, Hwang PA. Grand Rounds: Genetics. Hospital for Sick Children. Toronto, Canada. Jan 21, 2005. PRESENTATION.
• Hyperphosphatasia with mental retardation: a pyridoxine-responsive disorder?  Thompson MD, Killoran A, Burnham WM, Percy ME, Nezarati M, Hwang PA, and Cole DEC.  American Clinical Neurophysiology Society Annual Meeting. Montreal, Canada. Oct 2, 2004. PRESENTATION.
• Regulation and function of disulphide oxidoreductases in Salmonella typhimurium.  Suntharalingam P,  Gallant C, Bouwman C, Ponnampalam T, Killoran A, and Martin NL.  Third Annual Meeting for Basic and Clinical Research Trainees, Faculty of Health Sciences, Queen’s University, Canada. June 7, 2000. PRESENTATION

Why did you choose to become part of Michigan State University Neurology?

So that I could have the opportunity to contribute to this splendid website!

If you were not a doctor, what would you have chosen as a career?

Researcher or Superstar in Broadway Musicals.

Extracurricular interests and activities:

In the good old days, I whiled away my carefree existence with activities such as trekking the Himalayas, rafting through white water rapids and riding camels across exotic deserts.  Now that I am in the US, I mostly just try to counteract the natural tendency to expand.